NYSE:LH
Laboratory Corp of America Holdings Stock News
$207.67
+1.52 (+0.737%)
At Close: May 10, 2024
LabCorp (LH) to Offer New Test Report for Venom Allergy Testing
04:41pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
LabCorp's (LH) newly-launched interpretative venom allergy report will inform enhanced treatment decisions in case of venomous insect stings.
LabCorp (LH) to Report Q2 Earnings: What's in the Cards?
01:16pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
LabCorp's (LH) Diagnostics base business organic volume is anticipated to have continued its rally in Q2, led by consistent growth in esoteric and routine procedures.
Labcorp to Announce Second Quarter Financial Results on July 28, 2022
05:43pm, Thursday, 14'th Jul 2022
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, Ju
LabCorp (LH) Debuts NfL Test for Neuronal Damage Diagnosis
03:42pm, Thursday, 14'th Jul 2022 Zacks Investment Research
LabCorp's (LH) widely accessible NfL blood test presents direct evidence of neuronal injury resulting from brain injury or diseases like Alzheimer's, among others.
LabCorp (LH) Debuts NfL Test for Neuronal Damage Diagnosis
01:10pm, Thursday, 14'th Jul 2022
LabCorp's (LH) widely accessible NfL blood test presents direct evidence of neuronal injury resulting from brain injury or diseases like Alzheimer's, among others.
LabCorp's (LH) Base Testing Volume Grows, Costs Rise
03:31pm, Friday, 08'th Jul 2022 Zacks Investment Research
LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.
LabCorp's (LH) Base Testing Volume Grows, Costs Rise
01:13pm, Friday, 08'th Jul 2022
LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.
LabCorp (LH) to Offer Monkeypox Test, Double CDC's Capacity
01:39pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Labcorp (LH) is set to become the first national laboratory to offer this PCR test, verified for the CDC.
LabCorp (LH) to Offer Monkeypox Test, Double CDC's Capacity
10:50am, Thursday, 07'th Jul 2022
Labcorp (LH) is set to become the first national laboratory to offer this PCR test, verified for the CDC.
LabCorp (LH) to Strengthen Laboratory Footprint in Japan
04:25pm, Monday, 04'th Jul 2022 Zacks Investment Research
LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.
LabCorp (LH) to Strengthen Laboratory Footprint in Japan
02:00pm, Monday, 04'th Jul 2022
LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.
5 ‘Strong Buy' BofA Securities Value 10 Stocks With Very Dependable Dividends
07:19am, Tuesday, 28'th Jun 2022
For years, analysts and portfolio managers have anticipated the return of value stocks as the market moved higher.
LabCorp (LH) Partners HealthVerity to Grow in Drug Development
01:47pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
According to LabCorp (LH), this partnership is expected to broaden its comprehensive, end-to-end drug development and clinical trial programs.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
04:11pm, Tuesday, 21'st Jun 2022 Zacks Investment Research
Investors are optimistic about LabCorp's (LH) robust Drug Development business performance and several pandemic-related developments.
Here's Why Investors Should Retain LabCorp (LH) Stock for Now
01:27pm, Tuesday, 21'st Jun 2022
Investors are optimistic about LabCorp's (LH) robust Drug Development business performance and several pandemic-related developments.
